Chief Scientific Officer Stauderman Kenneth A. bought $3,960 worth of shares (1,000 units at $3.96) and sold $3,650 worth of shares (1,000 units at $3.65), increasing direct ownership by 8% to 12,944 units (SEC Form 4)